Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report

Nivolumab, an antiprogrammed death-1 checkpoint inhibitor, has been approved for use in unresectable/metastatic renal cell carcinoma (RCC). Nivolumab-induced pneumonitis, a rare, but often severe and potentially life-threatening immune-related adverse event, has been reported, typically, early durin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Case Rep Oncol Med
Hoofdauteurs: Mendiola, Vincent Louie, Kesireddy, Meghana, Jana, Bagi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi 2019
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944973/
https://ncbi.nlm.nih.gov/pubmed/31949965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6759472
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items